Clinical and pathological features of patients (data in parentheses are percentages)
| Characteristics | |
| No. of evaluable patients | 279 |
| Age (years) | |
| Median | 65 |
| Range | 29–97 |
| Follow time (months) | |
| Median | 46.32 |
| Range | (0–137.16) |
| Stage | |
| I | 181 (64.87) |
| II | 35 (12.54) |
| III | 43 (15.41) |
| IV | 20 (7.17) |
| Subtype | |
| Endometrioid | 202 (72.4) |
| CCC+serous | 77 (27.6) |
| Grade (FIGO) | |
| 1 | 119 (42.65) |
| 2 | 53 (19) |
| 3 | 107 (38.35) |
| Grade (nuclear) | |
| 1 | 93 (33.33) |
| 2 | 75 (26.88) |
| 3 | 111 (39.78) |
| Tumour size (cm) | |
| ≤2 | 62 (22) |
| >2 | 217 (78) |
| Depth of invasion | |
| Median | 28 |
| Range | 0–100 |
| LVI | |
| No | 202 (72.4) |
| Yes | 77 (27.6) |
| Lymph node status | |
| Positive | 50 (17.92) |
| Negative | 135 (48.39) |
| Unknown | 94 (33.69) |
| Recurrence | |
| No | 215 (77.06) |
| Yes | 47 (16.85) |
| Persistent | 12 (4.3) |
| Progression | 4 (1.43) |
| Unknown | 1 (0.36) |
| Status | |
| ANED | 188 (67.38) |
| AWED | 22 (7.89) |
| DOD | 38 (13.62) |
| DNED | 22 (7.89) |
| Dead unknown cause | 1 (0.36) |
| DWED | 7 (2.51) |
| Lost for FU | 1 (0.36) |
ANED, alive with no evidence of disease; AWED, alive with evidence of disease; CCC, clear cell carcinoma; DOD, dead of disease; DNED, dead with no evidence of disease; DWED, dead with evidence of disease; FIGO, International Federation of Gynecology and Obstetrics; LVI, lymphovascular invasion.